Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001422882-12-000007
Filing Date
2012-01-17
Accepted
2012-01-17 17:45:26
Documents
1
Period of Report
2012-01-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3968
  Complete submission text file 0001422882-12-000007.txt   5619
Mailing Address C/O OXIGENE, INC. 230 THIRD AVENUE WALTHAM MA 02451
Business Address
Chin Richard (Reporting) CIK: 0001337252 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 12530455

Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations